Stockreport

Institutions own 21% of Clinuvel Pharmaceuticals Limited (ASX:CUV) shares but retail investors control 59% of the company [Yahoo! Finance]

CLINUVEL PHARMS LTD S/ADR  (CLVLY) 
NASDAQ:AMEX Investor Relations: clinuvel.com/investors
PDF 41% of the business is held by the top 25 shareholders Insider ownership in Clinuvel Pharmaceuticals is 14% To get a sense of who is truly in control of Clinuvel Ph [Read more]